Vertex Pharmaceuticals
VRTX
#172
Rank
S$162.59 B
Marketcap
S$641.93
Share price
-0.94%
Change (1 day)
20.77%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): S$6.49 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are S$12.58 Billion. In 2025 the company made an earning of S$6.17 Billion, an increase over its 2024 earnings that were of S$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$6.49 B5.15%
2025 S$6.17 B1627.59%
2024 S$0.35 B-93.69%
2023 S$5.66 B3.19%
2022 S$5.49 B53.56%
2021 S$3.57 B-12.06%
2020 S$4.06 B118.45%
2019 S$1.86 B120.64%
2018 S$0.84 B1473.64%
2017 S$53.64 M197.6%
2016 S$18.02 M-102.97%
2015 -S$0.61 Billion-28.46%
2014 -S$0.85 Billion-51.5%
2013 -S$1.75 Billion-30584.68%
2012 S$5.73 M-95.47%
2011 S$0.12 B
2009 -S$0.76 Billion
2007 -S$0.53 Billion83.1%
2006 -S$0.29 Billion59.02%
2005 -S$0.19 Billion3.28%
2004 -S$0.18 Billion-38.16%
2003 -S$0.29 Billion
2000 -S$48.76 Million-20.38%
1999 -S$61.23 Million31.62%
1998 -S$46.52 Million91.05%
1997 -S$24.35 Million-36.24%
1996 -S$38.19 Million12.45%
1995 -S$33.97 Million27.4%
1994 -S$26.66 Million-1833.33%
1993 S$1.53 M-112.12%
1992 -S$12.69 Million175%
1991 -S$4.62 Million-12.2%
1990 -S$5.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.58 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$11.14 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.51 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.85 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.26 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-S$64.36 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA